| Sanofi-Aventis (Suisse) SA - Renagel, comprimés pelliculés | | 56297 | | 01 | | Renagel | | comprimés pelliculés | | V03AE02 | | Sevelamer | | 10.02.2004 | | |
| | Composition | | sevelameri hydrochloridum 800 mg, silica colloidalis anhydrica, acidum stearicum, aqua purificata, pellicule: hypromellosum, monoglyceriderorum diacetylates, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 800 mg |
| | | | Inactive agents | | additional_information |
|---|
| | | | | Aqua Purificata | | | | Hypromellosum | | pellicule | | | | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 180 Tablet(s) | 150.43 | 180.00 | B | SL | No |
|
|
